Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
22.97
-1.13 (-4.69%)
Dec 27, 2024, 4:00 PM EST - Market closed
Neurogene Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 |
| Dec '24 Dec 27, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 341 | 249 | - | - |
| Enterprise Value | 215 | 452 | - | - |
| Last Close Price | 22.97 | 19.38 | - | - |
| PE Ratio | - | 18.20 | - | - |
| PB Ratio | 2.17 | 1.34 | - | - |
| P/TBV Ratio | 3.97 | 1.34 | - | - |
| Debt / Equity Ratio | 0.10 | 0.08 | 0.05 | 0.06 |
| Quick Ratio | 8.84 | 8.61 | 12.48 | 6.57 |
| Current Ratio | 9.09 | 8.72 | 12.74 | 6.81 |
| Return on Equity (ROE) | -53.63% | -25.52% | -59.77% | - |
| Return on Assets (ROA) | -39.75% | -20.94% | -33.52% | - |
| Return on Capital (ROIC) | -43.84% | -22.83% | -36.31% | - |
| Earnings Yield | -0.96% | -14.61% | - | - |
| FCF Yield | -20.82% | -20.82% | - | - |
| Buyback Yield / Dilution | -116.71% | -1080.37% | 90.26% | - |
| Total Shareholder Return | -116.71% | -1080.37% | 90.26% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.